Noncontraceptive Use of Contraceptive Agents

被引:1
|
作者
Nickles, Monique Collier [1 ]
Alderman, Elizabeth [2 ,3 ]
机构
[1] Lincoln Med & Mental Hlth Ctr, Dept Pediat, Bronx, NY 10451 USA
[2] Childrens Hosp Montefiore, Div Adolescent Med, Dept Pediat, Bronx, NY USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
D O I
10.1542/pir.35-6-229
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Educational Gap According to 2006-2008 National Survey of Family Growth data, 33% of adolescents ages 15 to 19 years using combined oral contraceptives do so solely for noncontraceptive reasons, mostly to alleviate problems and symptoms associated with menstrual periods. Consequently, it is necessary for physicians to become more knowledgeable of the known health benefits and noncontraceptive uses of contraceptive agents to enhance their treatment and care for adolescent patients. (1) Objectives After completing this article, readers should be able to: 1. Identify medical conditions treatable with hormonal contraception. 2. Identify noncontraceptive benefits of contraceptive agents for adolescents. 3. Recognize conditions and diseases for which menstrual regulation or suppression can benefit adolescents, improve disease outcome, and enhance quality of life. 4. List the relative and absolute contraindications to the use of combined hormonal contraceptives. 5. Describe different contraceptive methods available for use.
引用
收藏
页码:229 / 242
页数:14
相关论文
共 50 条
  • [21] Use Patterns and Concomittant Use of Isotretinoin and Contraceptive Agents before and after iPLEDGE Implementation
    Pinheiro, Simone P.
    Kang, Elizabeth M.
    Governale, Laura A.
    Zhou, Esther H.
    Kim, Clara Y.
    Hammad, Tarek A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S220 - S221
  • [22] PHARMACOLOGY OF CONTRACEPTIVE AGENTS
    ODELL, WD
    MOLITCH, ME
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1974, 14 : 413 - 434
  • [23] Urethritis simplex and genital eczema after use of contraceptive agents.
    Dietel, Friedrich
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1931, 57 : 1197 - 1198
  • [24] OPHTHALMOLOGICAL INCIDENTS AND ACCIDENTS RELATED TO USE OF ORAL-CONTRACEPTIVE AGENTS
    ARDOUIN, M
    URVOY, M
    OUEST MEDICAL, 1977, 30 (22): : 1583 - 1586
  • [25] NONCONTRACEPTIVE USE OF THE LEVONORGESTREL INTRAUTERINE SYSTEM IN A MANAGED CARE SETTING
    Sinclair, F.
    Pressman, A.
    Maloney, K.
    CONTRACEPTION, 2009, 80 (02) : 198 - 198
  • [26] Introduction: Noncontraceptive use of steroid sex hormones in reproductive medicine
    Barnhart, Kurt T.
    FERTILITY AND STERILITY, 2016, 106 (07) : 1551 - 1551
  • [28] SERUM-LIPID ALTERATIONS ASSOCIATED WITH USE OF ORAL-CONTRACEPTIVE AGENTS
    DAWSON, EB
    FREY, MJ
    MONISTERE, N
    MCGANITY, WJ
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1975, 28 (04): : 429 - 429
  • [29] SERUM-LIPID ALTERATIONS ASSOCIATED WITH USE OF ORAL-CONTRACEPTIVE AGENTS
    DAWSON, EB
    FREY, MJ
    MONISTERE, N
    MCGANITY, WJ
    CLINICAL RESEARCH, 1975, 23 (03): : A461 - A461
  • [30] USE OF ESTROGENS AS POSTCOITAL CONTRACEPTIVE AGENTS - CLINICAL EFFECTIVENESS AND POTENTIAL MODE OF ACTION
    BLYE, RP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 116 (07) : 1044 - 1050